NewAmsterdam Pharma Co N.V. ($NAMS)
Filing Information
| Accession Number | 0001193125-26-009272 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 10, 2026 |
| Document Date | Jan 7, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
456,582
Total Value
$0.00
P&L
+inf% (+$10,534,160.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Ordinary Shares | โ | Jan 7, 2026 | Sale | 11,582 | โ | โ | 378,859 | Direct | โ | View Details | |
Director | Ordinary Shares | โ | Jan 7, 2026 | Grant/Award | 81,000 | โ | โ | 459,859 | Direct | โ | View Details | |
Director | Option (right to buy) | Derivative | Jan 7, 2026 | Grant/Award | 364,000 | $0.00 | $0.00 | 364,000 | Direct | โ | View Details |